TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines

IntroductionT-cell immunoglobulin and mucin domain-3 (TIM-3) is a transmembrane molecule first identified as an immunoregulator. This molecule is also expressed on leukemic cells in acute myeloid leukemia and master cell survival and proliferation. In this study, we aimed to explore the effect of TI...

Full description

Bibliographic Details
Main Authors: Mahnaz Rezaei, Mustafa Ghanadian, Behrooz Ghezelbash, Abolfazl Shokouhi, Alexandr V. Bazhin, Andrey A. Zamyatnin, Mazdak Ganjalikhani-Hakemi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267578/full
_version_ 1827763698472583168
author Mahnaz Rezaei
Mustafa Ghanadian
Behrooz Ghezelbash
Abolfazl Shokouhi
Alexandr V. Bazhin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Mazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi
author_facet Mahnaz Rezaei
Mustafa Ghanadian
Behrooz Ghezelbash
Abolfazl Shokouhi
Alexandr V. Bazhin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Mazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi
author_sort Mahnaz Rezaei
collection DOAJ
description IntroductionT-cell immunoglobulin and mucin domain-3 (TIM-3) is a transmembrane molecule first identified as an immunoregulator. This molecule is also expressed on leukemic cells in acute myeloid leukemia and master cell survival and proliferation. In this study, we aimed to explore the effect of TIM-3 interaction with its ligand galectin-9 (Gal-9) on glucose and lipid metabolism in AML cell lines.MethodsHL-60 and THP-1 cell lines, representing M3 and M5 AML subtypes, respectively, were cultured under appropriate conditions. The expression of TIM-3 on the cell surface was ascertained by flow cytometric assay. We used real-time PCR to examine the mRNA expression of GLUT-1, HK-2, PFKFB-3, G6PD, ACC-1, ATGL, and CPT-1A; colorimetric assays to measure the concentration of glucose, lactate, GSH, and the enzymatic activity of G6PD; MTT assay to determine cellular proliferation; and gas chromatography–mass spectrometry (GC-MS) to designate FFAs.ResultsWe observed the significant upregulated expression of GLUT-1, HK-2, PFKFB-3, ACC-1, CPT-1A, and G6PD and the enzymatic activity of G6PD in a time-dependent manner in the presence of Gal-9 compared to the PMA and control groups in both HL-60 and THP-1 cell lines (p > 0.05). Moreover, the elevation of extracellular free fatty acids, glucose consumption, lactate release, the concentration of cellular glutathione (GSH) and cell proliferation were significantly higher in the presence of Gal-9 compared to the PMA and control groups in both cell lines (p < 0.05).ConclusionTIM-3/Gal-9 ligation on AML cell lines results in aerobic glycolysis and altered lipid metabolism and also protects cells from oxidative stress, all in favor of leukemic cell survival and proliferation.
first_indexed 2024-03-11T10:54:44Z
format Article
id doaj.art-e4b781bf68234e0bbc8635549295e17b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-11T10:54:44Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e4b781bf68234e0bbc8635549295e17b2023-11-13T11:26:53ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-11-011410.3389/fimmu.2023.12675781267578TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell linesMahnaz Rezaei0Mustafa Ghanadian1Behrooz Ghezelbash2Abolfazl Shokouhi3Alexandr V. Bazhin4Andrey A. Zamyatnin5Andrey A. Zamyatnin6Andrey A. Zamyatnin7Andrey A. Zamyatnin8Mazdak Ganjalikhani-Hakemi9Mazdak Ganjalikhani-Hakemi10Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Pharmacognosy, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranEndocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, IranDepartment of General, Visceral and Transplant Surgery, Ludwig Maximilians University of Munich, Munich, GermanyFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, RussiaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, RussiaScientific Center for Translation Medicine, Sirius University of Science and Technology, Sochi, RussiaInstitute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, RussiaDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranRegenerative and Restorative Medicine Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, TürkiyeIntroductionT-cell immunoglobulin and mucin domain-3 (TIM-3) is a transmembrane molecule first identified as an immunoregulator. This molecule is also expressed on leukemic cells in acute myeloid leukemia and master cell survival and proliferation. In this study, we aimed to explore the effect of TIM-3 interaction with its ligand galectin-9 (Gal-9) on glucose and lipid metabolism in AML cell lines.MethodsHL-60 and THP-1 cell lines, representing M3 and M5 AML subtypes, respectively, were cultured under appropriate conditions. The expression of TIM-3 on the cell surface was ascertained by flow cytometric assay. We used real-time PCR to examine the mRNA expression of GLUT-1, HK-2, PFKFB-3, G6PD, ACC-1, ATGL, and CPT-1A; colorimetric assays to measure the concentration of glucose, lactate, GSH, and the enzymatic activity of G6PD; MTT assay to determine cellular proliferation; and gas chromatography–mass spectrometry (GC-MS) to designate FFAs.ResultsWe observed the significant upregulated expression of GLUT-1, HK-2, PFKFB-3, ACC-1, CPT-1A, and G6PD and the enzymatic activity of G6PD in a time-dependent manner in the presence of Gal-9 compared to the PMA and control groups in both HL-60 and THP-1 cell lines (p > 0.05). Moreover, the elevation of extracellular free fatty acids, glucose consumption, lactate release, the concentration of cellular glutathione (GSH) and cell proliferation were significantly higher in the presence of Gal-9 compared to the PMA and control groups in both cell lines (p < 0.05).ConclusionTIM-3/Gal-9 ligation on AML cell lines results in aerobic glycolysis and altered lipid metabolism and also protects cells from oxidative stress, all in favor of leukemic cell survival and proliferation.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267578/fullacute myeloid leukemiaTIM-3immunometabolismglucose metabolismlipid metabolismgalectin-9
spellingShingle Mahnaz Rezaei
Mustafa Ghanadian
Behrooz Ghezelbash
Abolfazl Shokouhi
Alexandr V. Bazhin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Andrey A. Zamyatnin
Mazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi
TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
Frontiers in Immunology
acute myeloid leukemia
TIM-3
immunometabolism
glucose metabolism
lipid metabolism
galectin-9
title TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
title_full TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
title_fullStr TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
title_full_unstemmed TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
title_short TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
title_sort tim 3 gal 9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
topic acute myeloid leukemia
TIM-3
immunometabolism
glucose metabolism
lipid metabolism
galectin-9
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267578/full
work_keys_str_mv AT mahnazrezaei tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT mustafaghanadian tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT behroozghezelbash tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT abolfazlshokouhi tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT alexandrvbazhin tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT andreyazamyatnin tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT andreyazamyatnin tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT andreyazamyatnin tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT andreyazamyatnin tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT mazdakganjalikhanihakemi tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines
AT mazdakganjalikhanihakemi tim3gal9interactionaffectsglucoseandlipidmetabolisminacutemyeloidleukemiacelllines